Are COVID-19 Vaccines in Pregnancy as Safe and Effective as they claimed
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as they claimed?
Just as the scientific method demands rigorous examination of hypotheses through empirical evidence, they must scrutinise the prevailing claims about COVID-19 vaccine safety during pregnancy with the same intellectual honesty that characterises genuine scientific inquiry. This comprehensive analysis examines whether the safety and efficacy assertions made by the medical industrial complex align with the observable data from regulatory databases. Through systematic investigation of adverse event reporting systems and clinical outcomes, they will explore the intersection of scientific evidence, public health policy, and legal frameworks that govern vaccine recommendations for pregnant women. The evidence-based approach presented here challenges readers to consider whether current policies reflect objective scientific analysis or institutional bias, demanding the same sceptical scrutiny that advances all legitimate scientific understanding.
The Data Behind Vaccine Safety Claims
The VAERS database analysis spanning 412 months reveals unprecedented safety signal breaches across all 37 pregnancy-related adverse events following COVID-19 vaccination. Researchers extracted comprehensive data comparing adverse events in pregnant women who received COVID-19 vaccines during 40 months against those who received influenza vaccines and all other vaccines combined over the full 412-month timeframe. The methodology employed proportional reporting ratios (PRR) and Chi-square analysis according to established CDC/FDA protocols, with safety thresholds clearly defined as PRR ≥ 2 or Chi-square ≥ 4.
Statistical analysis reveals that the mean PRR value reached 69.3, with individual ratios ranging from 5.37 to 499, representing deviations far beyond any previously documented vaccine safety concerns. The z-statistic calculations show standard deviations averaging 9.64 across the dataset, with most p-values falling below 0.000001, which is an imperatively one-in-a-million probability level. These mathematical expressions of risk represent not merely statistical anomalies but systematic patterns that suggest fundamental safety concerns, which regulatory agencies have consistently overlooked or dismissed.
Analysing Adverse Events in Pregnancy
Examination of the 37 documented adverse events reveals a comprehensive spectrum of pregnancy complications spanning both antepartum and postpartum periods. Twenty-seven antepartum events include miscarriage, chromosomal abnormalities, fetal malformations, cervical insufficiency, and placental disorders, while ten postpartum/newborn events encompass conditions such as newborn asphyxia and neonatal death. The data demonstrate that every single adverse event category exceeded FDA safety thresholds, with no exceptions—a phenomenon unprecedented in the history of vaccine safety surveillance.
Placental pathology emerged as particularly concerning, with ultrasound imaging documenting calcifications, lacunae, and infarcts in third-trimester pregnancies following earlier COVID-19 vaccination. These findings correlate directly with reported adverse events, including placental insufficiency, placental thrombosis, and placenta accreta. Clinical observations from sonographers and physicians reviewing prenatal imaging have consistently identified these abnormal placental features, suggesting a mechanistic relationship between vaccination and placental dysfunction that extends beyond statistical correlation.
Adverse Event Category | Safety Signal Breach Magnitude |
---|---|
Miscarriage | PRR is significantly above the threshold |
Foetal Malformations | Chi-square >4 requirement exceeded |
Placental Abnormalities | Multiple PRR breaches documented |
Stillbirth | Statistical significance p<0.000001 |
Newborn Death | Z-statistic indicating extreme deviation |
Chromosomal Abnormalities | PRR threshold exceeded substantially |
Comparing COVID-19 Vaccines to Historical Data
Historical vaccine safety data provide imperative context for evaluating the magnitude of observed adverse events. Pfizer’s post-market surveillance analysis documented 42,086 casualties, including 1,223 deaths, within just 10 weeks, establishing an injury-to-death ratio of 33.4 – a figure that dwarfs any previous pharmaceutical product safety profile. The company’s internal documentation revealed an 81% miscarriage rate among pregnancies with known outcomes, alongside five-fold increases in stillbirth rates and eight-fold increases in neonatal death rates compared to expected baseline values.
Comparative analysis against decades of influenza vaccine data exposes the stark contrast in safety profiles between COVID-19 vaccines and established immunisation programs. The 412-month historical dataset encompasses multiple vaccine types administered to pregnant women, yet none approached the adverse event rates documented with COVID-19 vaccines during their brief 40-month deployment period.
A Public Health Dilemma: Policy vs. Reality
The stark disconnect between official recommendations and empirical evidence creates an unprecedented schism in modern medicine. VAERS data reveal proportional reporting ratios averaging 69.3 across 37 pregnancy-related adverse events, yet public health authorities continue to promote COVID-19 vaccination during pregnancy as safe and effective. This chasm between statistical reality and policy positions healthcare providers in an untenable position, forcing them to reconcile professional observations with institutional mandates that appear increasingly divorced from scientific evidence.
Healthcare practitioners find themselves navigating treacherous waters where clinical judgment conflicts with administrative directives. The American Board of Obstetrics and Gynaecology threatened to revoke the licenses of physicians who questioned COVID-19 vaccine safety in pregnancy, despite mounting evidence of safety signal breaches. This institutional coercion transforms medicine from a scientific discipline into a bureaucratic compliance exercise, where practitioners must choose between upholding professional integrity and preserving their careers.
The Role of the CDC and FDA in Vaccine Recommendations
Both agencies established clear thresholds for safety concerns—a proportional reporting ratio of ≥2 or a Chi-square of ≥4—yet they simultaneously ignored their criteria when COVID-19 vaccines consistently exceeded these limits by orders of magnitude. The CDC’s Advisory Committee on Immunisation Practices proceeded with recommendations despite Pfizer’s post-market surveillance data showing an 81% miscarriage rate (26/32 cases with follow-up) and injury-to-death ratios of 33.4 within the first ten weeks of rollout. This selective application of established safety protocols suggests regulatory capture rather than scientific oversight.
The FDA’s attempt to seal Pfizer’s safety data for 55-75 years represents an extraordinary departure from transparency principles that underpin public health credibility. Their own VAERS database documented safety signal breaches across all 37 pregnancy-related adverse events, with p-values reaching one in a million or less, yet they maintained public assurances of safety. This pattern of data suppression while promoting continued use creates a regulatory framework that prioritises policy continuity over patient protection.
Misalignments in Public Messaging
Official communications consistently emphasised vaccine benefits while systematically downplaying or omitting adverse event data that exceeded established safety thresholds. The CDC promoted COVID-19 vaccination during pregnancy despite knowing that stillbirth rates increased fivefold and neonatal death rates increased eightfold compared to baseline expectations in Pfizer’s documentation. Public health messaging characterised these interventions as “safe and effective” while simultaneously acknowledging insufficient long-term safety data—a contradiction that undermines informed consent principles.
Professional medical organisations amplified government messaging without independent analysis of underlying data, creating an echo chamber that reinforced official positions regardless of emerging evidence. The American Board of Obstetrics and Gynaecology issued threats against 60,000 physicians who raised safety concerns, effectively silencing professional discourse and transforming medical practice from evidence-based decision-making into ideological conformity. This messaging strategy prioritised public compliance over scientific accuracy, creating a communication framework that resembled propaganda more than health education.
The messaging apparatus systematically dismissed or marginalised healthcare providers who reported adverse events consistent with VAERS data trends. Obstetricians who documented placental abnormalities, including calcifications, infarcts, and thrombosis, following COVID-19 vaccination, found their clinical observations labelled as “misinformation” despite aligning with documented safety signals. This suppression of clinical reporting created a feedback loop in which adverse events went unacknowledged in official channels, while continuing to accumulate in surveillance databases, thereby perpetuating the disconnect between policy and reality.
The Legal Implications of Vaccine Administration
The unprecedented safety signal breaches documented in this analysis create profound legal ramifications that extend far beyond traditional medical malpractice considerations. Healthcare providers who administered COVID-19 vaccines to pregnant patients despite these documented safety signals exceeding CDC/FDA thresholds by margins of 69.3 (PRR) and 74.7 (Chi-square) may face liability exposure under multiple legal theories. The Pfizer 5.3.6 post-market surveillance data, which documented an 81% miscarriage rate and attempted concealment for 55-75 years, establishes a pattern of institutional knowledge regarding harm that was systematically withheld from both practitioners and patients.
Professional licensing boards, exemplified by ABOG’s September 2021 threats against 60,000 Ob/Gyn physicians, created an environment where practitioners faced career destruction for questioning vaccine safety in pregnancy. The 98-page open letter to ABOG documented specific breaches of VAERS safety signals. Yet, regulatory bodies continued to mandate recommendations despite statistical evidence showing p-values in the range of one in a million or less for adverse pregnancy outcomes. This regulatory capture scenario presents unique legal challenges where traditional medical standard-of-care defences may prove inadequate when governing bodies themselves ignore their safety thresholds.
Understanding Liability and Accountability
Traditional vaccine injury compensation through the National Vaccine Injury Compensation Program (VICP) does not apply to COVID-19 vaccines, which fall under the Countermeasures Injury Compensation Program (CICP) with significantly more restrictive compensation criteria. The CICP has historically compensated fewer than 4% of claims and provides no legal recourse for denied claims, leaving injured parties with limited options despite documented safety signal breaches exceeding FDA thresholds by factors of 10 to 250 times. Healthcare providers cannot rely on standard vaccine liability protections when safety signals were systematically ignored, particularly given the documented attempt to conceal Pfizer’s post-market analysis showing 42,086 casualties, including 1,223 deaths, in just 10 weeks.
Individual practitioners face potential liability under state medical malpractice laws, particularly those who continued administering COVID-19 vaccines to pregnant patients after January 12, 2022, when ABOG was formally notified of the unacceptable VAERS safety signal breaches. The legal doctrine of informed consent requires disclosure of material risks, yet practitioners were operating under regulatory guidance that contradicted their own agencies’ safety thresholds, creating a scenario where following official recommendations may constitute negligence per se. Institutional liability extends to hospitals and health systems that mandated COVID-19 vaccination for pregnant healthcare workers or patients, particularly given the documented placental abnormalities, including calcifications, infarctions, and thrombosis, visible on ultrasound imaging.
Navigating Informed Consent in Medical Practice
The systematic withholding of material safety information from both practitioners and patients fundamentally compromised the informed consent process for COVID-19 vaccination in pregnancy. Pfizer’s 5.3.6 analysis documented specific pregnancy risks, including an 81% miscarriage rate, a five-fold increase in stillbirths, and an eight-fold increase in neonatal deaths. Yet, this data was concealed from the medical community and pregnant women making vaccination decisions. The legal standard for informed consent requires disclosure of material risks that would influence a reasonable patient’s decision-making process, making the concealment of known adverse outcomes a potential basis for fraud and battery claims beyond traditional negligence theories.
Healthcare providers who administered COVID-19 vaccines to pregnant patients without disclosing the documented safety signal breaches may face allegations that they failed to obtain valid informed consent. The documentation of 37 pregnancy-related adverse events exceeding safety thresholds, with proportional reporting ratios ranging from 5.37 to 499 times normal levels, constitutes material information that should have been disclosed to patients. Professional licensing boards that threatened practitioners for discussing these safety concerns created an environment where informed consent became legally impossible, as providers were prohibited from sharing material risk information under threat of license revocation.
The emergence of characteristic placental pathology is visible on ultrasound, including calcifications.
Perspectives from the Medical Community
The medical establishment’s response to the mounting evidence of pregnancy-related adverse events following COVID-19 vaccination reveals a profession deeply divided along lines that transcend traditional scientific discourse. While official medical organisations continue to endorse universal vaccination recommendations for pregnant women, a growing cadre of practitioners has begun to question the fundamental assumptions underlying these policies. The American Board of Obstetrics and Gynaecology’s September 2021 statement threatening license revocation for physicians who disseminate “COVID-19 misinformation” represents an unprecedented attempt to silence scientific debate within the medical community, effectively transforming clinical practice from evidence-based medicine into compliance-based medicine.
This institutional pressure has created what many describe as a chilling effect on clinical reporting and professional discourse. Physicians who have observed unusual patterns of pregnancy complications following vaccination find themselves caught between their clinical observations and institutional mandates. The 98-page open letter to ABOG published in January 2022 by a senior board-certified obstetrician detailed specific VAERS safety signal breaches, yet received no formal response from the organisation, illustrating the extent to which professional medical bodies have insulated themselves from contradictory evidence. The letter’s documentation of unprecedented deaths, fetal malformations, and pregnancy losses represents a direct challenge to the medical establishment’s narrative that has been met with institutional silence rather than scientific engagement.
Divergent Opinions Among Obstetricians and Gynaecologists
Within the speciality of obstetrics and gynaecology, practitioners have found themselves navigating an increasingly polarised landscape where clinical observations often conflict with institutional directives. Many obstetricians report privately observing increased rates of placental abnormalities, including calcifications, lacunae, and infarcts in patients who received COVID-19 vaccines during pregnancy, yet feel constrained from discussing these observations openly due to professional repercussions. The ultrasound findings documented in Figure 1 of the study represent patterns that experienced sonographers and maternal-fetal medicine specialists recognise as departing significantly from normal placental development, yet these observations remain largely absent from peer-reviewed literature due to editorial policies that discourage vaccine-critical research.
The speciality’s governing bodies have effectively created a two-tier system of professional discourse: public endorsement of vaccination policies and private acknowledgement of concerning clinical patterns.ABOG’s threats to revoke board certifications for physicians questioning vaccine safety in pregnancy represent an unprecedented departure from the organisation’s historical role as a guardian of clinical standards rather than an enforcer of political orthodoxy. This has resulted in a generation of obstetricians who practice defensive medicine, recommending interventions they privately question while publicly maintaining adherence to institutional guidelines. The psychological burden on practitioners who witness adverse outcomes while being professionally prohibited from discussing causation has created what some describe as a crisis of medical conscience within the speciality.
Voices of Concern: Accounts from Health Professionals
Healthcare professionals across multiple specialities have begun documenting their experiences through informal networks and alternative professional forums, creating a parallel discourse that operates outside traditional medical publishing channels. Sonographers report observing placental abnormalities at rates they describe as “unprecedented” in their careers, with patterns of calcification and vascular compromise appearing earlier in pregnancy and with greater severity than previously encountered. These frontline healthcare workers, who perform thousands of ultrasounds annually, represent a particularly valuable source of observational data due to their extensive experience with normal versus abnormal placental development across diverse patient populations.
Nurses in labour and delivery units have reported increased rates of complications they associate temporally with COVID-19 vaccination, including preterm labour, placental abruption, and neonatal complications requiring intensive care intervention. The professional isolation experienced by healthcare workers who attempt to report these observations through official channels has led to the development of informal networks where practitioners share experiences and seek validation for their clinical concerns. Many describe feeling professionally gaslighted, with their observations dismissed as coincidental or attributed to pandemic-related stress rather than being investigated as potential vaccine-related adverse events.
The testimonies of these healthcare professionals reveal a pattern of institutional suppression that extends beyond individual cases to encompass systematic discouragement of adverse event reporting. Hospital administrators have reportedly discouraged staff from filing VAERS reports for pregnancy-related complications following vaccination, citing concerns.
The Intersection of Science and Ethical Considerations
The unprecedented safety signal breaches documented in the VAERS data—with proportional reporting ratios averaging 69.3 across 37 adverse events—force a fundamental reconsideration of how scientific evidence intersects with ethical obligations in medical practice. The magnitude of these deviations, where the CDC/FDA defines a PRR ≥ 2 as cause for alarm, yet researchers observed ratios reaching as high as 499, represents a chasm between regulatory thresholds and observed reality that cannot be bridged by statistical manipulation or institutional reassurance. The z-statistic of 9.64 indicates that these adverse events occur at rates that are nearly ten standard deviations above what would be expected from other vaccines, placing them in a statistical realm so extreme that they approach mathematical impossibility under the null hypothesis of equivalent safety.
Pfizer’s own 5.3.6 post-market surveillance analysis, which they attempted to conceal for 55-75 years, documented 42,086 casualties, including 1,223 deaths, in just 10 weeks, establishing an “injure-to-kill” ratio of 33.4 that defies any reasonable risk-benefit calculation for pregnant women. The ethical implications extend beyond individual patient care to encompass the integrity of the scientific method itself, as regulatory agencies continued to promote these interventions despite having access to data showing an 81% miscarriage rate among documented pregnancies and an eight-fold increase in neonatal death rates. This disconnect between available evidence and public health messaging raises profound questions about whether the scientific establishment has prioritised political expediency over empirical observation.
Balancing Public Health with Individual Risks
The traditional public health calculus of accepting small individual risks for broader societal benefits collapses entirely when confronted with the scale of adverse events documented in this analysis. All 37 pregnancy-related adverse events exceeded safety thresholds, with p-values predominantly in the range of one in a million or less, indicating that the probability of these observations occurring by chance approaches zero. The American Board of Obstetrics and Gynaecology’s threats to remove licenses and board certifications from physicians who questioned these interventions represent a fundamental inversion of medical ethics, where institutional compliance superseded the physician’s primary obligation to “first, not harm.”
The concentration of lipid nanoparticles in ovaries, as documented in regulatory submissions, combined with the observation that female fetuses possess only approximately one million gametes that must last their entire reproductive lifetime, transforms this from a question of immediate pregnancy outcomes to one of intergenerational reproductive health. Public health authorities failed to acknowledge that pregnant women represent a unique population where individual risk assessment cannot be subsumed under population-level statistics, as each pregnancy involves two distinct patients with potentially conflicting interests and vastly different risk tolerances.
Ethical Dilemmas in Emergency Use Authorisations
The Emergency Use Authorisation framework created an ethical paradox by simultaneously demanding urgent deployment while explicitly acknowledging insufficient safety data, particularly for pregnant women who were excluded from initial clinical trials. The 98-page open letter to ABOG detailed unprecedented deaths, fetal malformations, and pregnancy losses that were accumulating in real-time surveillance systems, yet regulatory agencies maintained their recommendations without acknowledging these emerging signals. The attempt to conceal Pfizer’s post-market analysis for multiple decades represents a violation of the fundamental principle of informed consent, as patients cannot make autonomous decisions without access to relevant safety information.
Emergency authorisation protocols traditionally require clear evidence that benefits outweigh risks, yet the data presented here suggests that for pregnant women, the risk profile was inverted from the beginning. The documentation of placental abnormalities, including calcifications, infarctions, and thrombosis in third-trimester ultrasounds following earlier vaccination, represents observable pathophysiological changes that should have triggered immediate safety reviews. The ethical framework governing emergency interventions assumes that uncertainty justifies action; however, this assumption becomes morally untenable when emerging evidence consistently points to harm rather than benefit.
The regulatory agencies’ continued promotion of these interventions in pregnancy, despite accumulating evidence of safety signal breaches across every monitored adverse event category, represents a fundamental failure of the precautionary principle.
Summing up
Taking this into account, the evidence presented in this comprehensive analysis reveals a stark contradiction between the assurances of official health authorities and the empirical data they have collected. The researchers have methodically demonstrated that COVID-19 vaccines in pregnancy breach every safety signal established by the CDC and FDA, with proportional reporting ratios averaging 69.2 times higher than those observed with influenza vaccines. When one considers that these safety thresholds were established precisely to identify potential hazards, the systematic violation of these parameters across all 37 pregnancy-related adverse events suggests a profound disconnect between public health messaging and scientific reality. The statistical significance of these findings, with p-values reaching one in a million or less, indicates that these patterns are improbable to have occurred by chance alone.
The implications extend beyond mere statistical anomalies to encompass fundamental questions about scientific integrity and institutional accountability. As recent policy discussions have begun to acknowledge, including RFK Jr., who says COVID shots are no longer recommended for kids or pregnant women, the mounting evidence suggests that the medical establishment may have prioritised narrative consistency over rigorous safety assessment. The researchers’ documentation of placental abnormalities, fetal complications, and neonatal adverse events presents a sobering counterpoint to the categorical safety claims that have dominated public discourse. They have illuminated a critical gap between the evidence-based medicine that should guide clinical practice and the policy-driven recommendations that have shaped vaccination programs, raising profound questions about how scientific institutions evaluate and communicate risk in the context of public health emergencies.
Watch our MedHeads episode on this topic
Key Takeaways:
- All 37 pregnancy-related adverse events following COVID-19 vaccination exceeded CDC/FDA safety thresholds by unprecedented margins, with proportional reporting ratios averaging 69.3 compared to the safety concern threshold of ≥2, and statistical significance reaching one-in-a-million probability levels or better.
- The study compared adverse events from COVID-19 vaccines administered over 40 months to influenza vaccines and all other vaccines administered over 412 months, finding severe safety signal breaches across complications including miscarriage, stillbirth, fetal malformations, placental abnormalities, and newborn deaths.
- Pfizer’s post-market surveillance data from February 2021 documented concerning pregnancy outcomes, including an 81% miscarriage rate, a five-fold increase in stillbirths, an eight-fold increase in neonatal deaths, and a 13% incidence of breastfeeding complications – data the company attempted to conceal for 55-75 years.
- Placental abnormalities showed substantial safety signal breaches and were documented through ultrasound imaging, revealing calcifications, infarcts, and other pathological changes consistent with multiple pregnancy complications described in the study.
- The American Board of Obstetrics and Gynaecology was formally notified in January 2022 about unacceptable VAERS safety signal breaches, yet continued to threaten physicians who questioned COVID-19 vaccine recommendations during pregnancy with license revocation and loss of board certification.
FAQ
Q: What methodology did this study use to assess COVID-19 vaccine safety in pregnancy?
A: The study analysed data from the CDC/FDA Vaccine Adverse Event Reporting System (VAERS) database spanning from January 1, 1990, to April 26, 2024. Researchers compared adverse events (AEs) in pregnancy following COVID-19 vaccination (40 months of data) against influenza vaccines and all other vaccines (412 months of data). The analysis employed proportional reporting ratios (PRR), Chi-square analysis, and Fisher’s exact tests, in accordance with CDC/FDA guidance. The CDC/FDA consider a safety concern to exist when PRR is ≥ 2 or the Chi-square is ≥ 4.
Q: What were the key findings regarding pregnancy-related adverse events after COVID-19 vaccination?
A: The study found that all 37 pregnancy-related adverse events examined exceeded CDC/FDA safety signal thresholds. These included 27 antepartum complications (miscarriage, chromosomal abnormalities, fetal malformations, cervical insufficiency, fetal arrhythmia, haemorrhage, premature labour, preeclampsia, placental abnormalities, fetal growth restriction, stillbirth) and 10 postpartum/newborn complications (newborn asphyxia and death). The mean PRR was 69.2 (ranging from 5.3 to 499), dramatically exceeding the safety threshold of 2. All p-values were ≤ 0.001, with most being less than one in a million.
Q: How do these findings compare to what Pfizer’s own post-market surveillance revealed?
A: Pfizer’s legally mandated 5.3.6 post-market analysis documented concerning pregnancy outcomes within just 10 weeks, including an 81% miscarriage rate (26/32 cases with follow-up), a five-fold increase in stillbirth rates (from expected 5.8/1000 to 31/1000), an eight-fold increase in neonatal death rates (from expected 3.9/1000 to 31/1000), and a 13% incidence of breastfeeding complications. The document also reported 42,086 total adverse events including 1,223 deaths. Pfizer and the FDA attempted to conceal this analysis for 55-75 years.
Q: What specific placental abnormalities were observed in this study?
A: The study documented substantial safety signal breaches for multiple placental complications, including placental insufficiency, calcification, infarction, thrombosis, placenta accreta, and other placental disorders. Clinical ultrasound images from three women’s third-trimester pregnancies showed calcifications, lacunae, and infarcts. These findings were consistent with sonographer and physician observations and correlated with other pregnancy complications such as reduced amniotic fluid volume and fetal growth restriction. Placental abnormalities represent some of the most concerning findings, given their potential impact on fetal development.
Q: What was the response from medical organisations when these safety concerns were raised?
A: The American Board of Obstetrics and Gynaecology (ABOG) published a statement on September 27, 2021, threatening to remove licenses and board certifications of physicians who questioned COVID-19 vaccination recommendations in pregnancy. In response, a senior board-certified Ob/Gyn and maternal-fetal medicine physician published a 98-page open letter to ABOG on January 12, 2022, detailing the unacceptable breaches in VAERS safety signals. The letter warned about unprecedented deaths, fetal malformations, pregnancy losses, and concerns about lipid nanoparticles crossing placental barriers and concentrating in ovaries.